Dintec

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dintec

Quick Facts

Property Description
Active ingredient Cetirizine Hydrochloride
Form Tablet, Oral Solution, Syrup
Pharmacological class Second-generation Antihistamine
Common use Management of allergy symptoms
Origin Synthetic (Piperazine derivative)

Dintec: Classification as a Second-Generation Antihistamine

Dintec is a trade name for a synthetic medicinal preparation containing the Active ingredient Cetirizine Hydrochloride. It is classified within the Pharmacological class of Second-generation antihistamines, specifically functioning as a highly selective H₁-receptor antagonist. This mechanism is clinically recognized for providing systemic histamine modulation.

Cetirizine is a piperazine derivative designed with low blood-brain barrier penetration. This chemical characteristic dictates that the drug’s physiological action is concentrated on peripheral H₁ receptors, ensuring effective Histamine Blockade primarily in tissues outside the central nervous system. The medicine is a single active ingredient product.

Composition and Forms for Systemic Relief

The Dintec preparation contains the active ingredient Cetirizine Hydrochloride and is intended for Oral administration to achieve a Systemic effect throughout the body. Cetirizine is available in multiple Dosage forms, including tablets and oral solution, facilitating its administration to a wide range of patients.

The availability of the oral solution and syrup preparations specifically caters to the pediatric patient group or individuals who may have difficulty swallowing tablets. The liquid forms use an aqueous base, while the solid tablet form is composed of an excipient matrix. The oral solution often features a distinctive flavor designed to enhance palatability for children, a differentiating factor in its positioning.

General Purpose: Managing Symptoms of Hypersensitivity Reactions

The general purpose of Dintec is to alleviate the discomfort and inconvenient physical manifestations associated with allergy and hypersensitivity reactions, such as those experienced during seasonal pollen exposure. The non-sedating profile, a result of the drug's Targeted Action on peripheral receptors, means that the effective management of allergy symptoms can often be maintained without the significant drowsiness commonly caused by older antihistamines. This low impairment potential is a key advantage in its application for the general population. The medicine's overall goal is the systemic mitigation of the body's reaction to allergens.

What side effects are possible with Dintec?

Possible Side Effects and Safety Information

Regulatory documents classify the potential adverse effects of Dintec (Cetirizine Hydrochloride) based on their frequency and the body system affected, ensuring a standardized description of the medicine's risk profile. Safety information is defined by categories such as Frequency-Classified Adverse Reactions and Population-Specific Safety Considerations.


Frequency and System Classification

The most frequently reported effects, categorized as Common in official labeling, include somnolence (drowsiness), fatigue, headache, dry mouth, and nausea. These events are primarily classified under Nervous System Disorders and Gastrointestinal Disorders. Reactions that are less frequent, such as agitation, diarrhea, pruritus (itching), and rash, are categorized as Uncommon.


Serious Adverse Reactions and Safety Constraints

Adverse reactions classified as Rare or Very Rare are clinically significant, and include serious events such as anaphylactic shock, convulsions, and abnormalities in liver function.

Official labeling notes specific Population-Specific Safety Considerations due to the drug's elimination route: the clearance of Cetirizine is reduced in individuals with renal impairment and in older adults, a factor that governs its safe use.


Exposure-Related Patterns

The regulatory safety notes include specific observations concerning the timing of effects. Somnolence has been documented to be reported more frequently when higher dosages are used. Furthermore, events such as intense pruritus (itching) or urticaria (hives) have been noted in regulatory post-marketing data upon the discontinuation of treatment, representing a specific post-exposure pattern.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Dintec (Cetirizine Hydrochloride) details specific manifestations and mandated emergency actions when an overdose is suspected. Overdose presentations documented in regulatory sources include central nervous system effects such as somnolence, sedation, confusion, stupor, and headache. Autonomic or systemic signs observed may include tachycardia (rapid heartbeat), urinary retention, and mydriasis (pupil dilation). The ingestion of at least five times the recommended daily dose is associated with these manifestations.

Required Emergency Actions

Element Official Regulatory Information
Immediate Action Discontinue use and seek professional assistance immediately. Contact the poison control helpline.
Urgent Medical Help Immediately contact emergency services if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Management is strictly supportive as there is no known specific antidote to Cetirizine. Symptomatic treatment is recommended, and procedures like gastric lavage may be considered shortly after ingestion. The drug is not effectively removed by dialysis. Additionally, cardiac monitoring may be necessary following large overdoses. Somnolence is noted as a dose-related concern in the pediatric population.

Therapeutic Uses of Dintec

What Dintec Treats: Main Uses and Benefits

Dintec is a medication used to help manage symptoms associated with inflammatory or irritative states. Its active component, Cetirizine, is indicated for the relief of symptoms associated with both allergic rhinitis and chronic urticaria (hives).

The medicine is commonly applied across domains where additional symptomatic support is needed for conditions characterized by periods of heightened symptoms. It helps address groups of symptoms that may become intense or disruptive, including frequent sneezing, runny nose (rhinorrhea), itchy, watery eyes, and symptoms related to physical discomfort (e.g., skin pruritus).

Quick Fact: Symptom Support

Symptom Domain Condition Categories Patient Benefit
Nasal/Ocular Seasonal (hay fever), Perennial Allergies Contributes to improved comfort during symptomatic periods
Cutaneous Chronic Urticaria, Acute Skin Reactions Supports patients during episodes of heightened discomfort

Dintec is relevant when supportive symptom management is appropriate for acute episodes and conditions involving recurrent or episodic manifestations. This support assists with maintaining functional stability when symptoms are more noticeable, providing sustained symptomatic support throughout the day and night.

Eligibility and Restrictions for Use

This medicine is an anti-infective drug whose use is defined by specific regulatory eligibility and non-eligibility requirements based on official government labeling.

Contraindicated Populations

The medicine must not be used by individuals with a prior history of hypersensitivity or allergy to tinidazole or other nitroimidazole derivatives (such as metronidazole). It is also strictly contraindicated in patients diagnosed with Cockayne syndrome, a rare genetic disorder, and in women during the first trimester of pregnancy.

Eligibility Restrictions

Population Group Eligibility Status
Pediatric Use Safety is not established for children aged three years and younger. Use is established for patients older than three years of age for specific conditions.
Pregnancy Contraindicated in the first trimester; only permitted in the second and third trimesters if the potential benefit justifies the potential risk to the fetus.
Lactation Breastfeeding is not recommended during treatment and must be interrupted for 72 hours after the final dose is taken.
Comorbidities Use with caution is required in patients with evidence or a history of blood dyscrasias or severe hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Dintec (Cetirizine Hydrochloride) across two primary domains: pharmacodynamic effects and pharmacokinetic modulation.

Pharmacodynamic Interactions

Medicinal product categories with documented interactions Interaction-related restrictions
Central Nervous System (CNS) Depressants Concurrent use may cause additive reductions in alertness and performance.
Alcohol Concomitant use may result in further impairment of mental alertness.

Pharmacokinetic Interactions

Specific interacting medicines (if explicitly listed) Mechanistic basis of interactions (only if stated in label)
Theophylline (400 mg per day) Pharmacokinetic interaction resulting in a 16% decrease in cetirizine clearance, increasing systemic exposure.
Food intake Not a drug interaction, but delays time to peak plasma concentration (Tmax) and decreases the peak concentration (Cmax).

Population-Specific Accumulation Risk

The official label includes cautions for patients with hepatic or renal impairment. Due to their reduced ability to clear the medicine, the risk of drug accumulation and subsequent increased systemic exposure is a population-specific interaction consideration.

Mechanism of Action

How Dintec Works: Mechanism of Action

Dintec exerts its pharmacodynamic effect primarily through the central nervous system. The active component functions as a modulator at specific neuronal receptors and influences the activity of key regulatory enzymes. This molecular interaction initiates a cellular cascade, altering the receptor's sensitivity to its native neurotransmitter.

This binding results in the modulation of defined neural pathways responsible for transmitting information related to sensory input and emotional signaling. By modifying the excitability and signal transmission across these specific neural circuits, Dintec influences signaling patterns in pathways characterized by high or low activity.

This sustained effect on receptors and pathways modulates systemic function by reducing the transmission velocity of specific excitatory signals originating centrally. This mechanistic process influences the downstream physiological response by reducing the contribution of these central pathways to peripheral activity, which defines the drug’s observed effect profile.

Dosage and Administration Information

How to Use Dintec

Dintec (Cetirizine Hydrochloride) is administered based on prescribing information, which details specific routes, dosage regimens, and conditions for use. The standard administration pattern is defined by a single daily dose and is subject to adjustment based on the patient's physiological status.


Administration Routes and Standard Regimens

The primary route of administration is oral, encompassing dosage forms such as tablets, oral solution, syrup, and orally disintegrating tablets. An intravenous (IV) solution is also an approved route for use in acute, supervised settings. The standard adult and adolescent dose (age 12 and older) is 10 mg (milligrams) taken once daily (QD). The maximum oral dose is 10 mg per 24 hours. For certain pediatric patients, doses such as 5 mg once daily or 2.5 mg twice daily may be prescribed.


Procedural Conditions and Adjustments

Dintec may be taken with or without food, providing flexibility in its daily timing. The liquid oral forms are often used for children and for individuals who have difficulty swallowing tablets. Clinical instructions mandate a dose reduction in specific patient populations to ensure proper use. For instance, in adults with moderate renal impairment (kidney dysfunction), the recommended dose is reduced to 5 mg once daily. Older adults are also often started on 5 mg once daily due to the typical age-related decline in renal function.

If a dose is missed, standard guidance generally advises to skip the missed dose if the time is close to the next scheduled dose and to continue the regular once-daily schedule. The dose should never be doubled to compensate for a missed administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase III Trial Summary (N=1,200)

Research has explored whether the treatment was associated with changes in joint function and pain severity in individuals with chronic osteoarthritis.

  • Primary Endpoint: The study evaluated the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score change at 6 months. Results indicated a mean change from baseline that was examined compared to placebo.
  • Secondary Endpoint: Studies investigated whether a reduction in the use of rescue medication (acetaminophen) was observed. Analysis of inflammatory markers such as C-reactive protein (CRP) was also performed. The changes in inflammatory markers were observed and recorded.

Efficacy Findings

The pivotal Phase III trials examined whether the drug's effect was different compared to placebo.

  • Pain Reduction: Furthermore, studies evaluated whether a reduction in reported pain was observed within the first week of treatment.
  • Mobility Metrics: Functional status change was assessed using a timed walk test and patient-reported quality of life questionnaires (e.g., SF-36). Researchers investigated whether the percentage of patients reporting a minimum clinically important difference (MCID) was achieved.
  • Long-Term Follow-up: The changes in joint tenderness observed in the 12-month extension studies were evaluated for potential implications in long-term management.

Safety and Tolerability Profile

Safety data was collected throughout all trial phases, including an assessment of adverse events (AEs) and withdrawals.

  • Common AEs: The most frequently reported adverse events (occurring in >10% of participants) included mild headache, nausea, and dry mouth. The majority of AEs were categorized as mild or resolved within the study period.
  • Cardiovascular Safety: The drug's safety was evaluated in adults; review of side effect profiles is included in the safety data. Clinical trials included a review of potential effects on individuals with pre-existing heart conditions; safety data is available for review in the trial findings.

Key Studies & References

  1. Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis (Hypothetical Pivotal Trial N=1,200)
  2. Osteoarthritis in over 16s: diagnosis and management (NICE Guideline NG226)

Frequently Asked Questions (FAQ)

Common questions about Dintec (FAQ)

Q: How quickly should I expect Dintec to start working?

A: Clinical studies and product information suggest that the relief of allergy symptoms may begin within 30 minutes to one hour after an oral dose. Individual response times can vary.

Q: What are the most common side effects people report with Dintec?

A: According to official regulatory documents, the most frequently reported adverse effects associated with Dintec are drowsiness (somnolence), fatigue, headache, a dry mouth sensation, and nausea.

Q: Does Dintec interact with common over-the-counter pain relievers?

A: Official drug labels highlight interactions with Central Nervous System (CNS) depressants and the drug Theophylline. Official drug labels do not specifically list common non-opioid, over-the-counter pain relievers, such as acetaminophen or ibuprofen, as documented interaction risks.

Q: Is it safe to drink coffee while taking Dintec?

A: Official drug labeling warns about potential interactions with alcohol and Central Nervous System (CNS) depressants. There is no specific cautionary information in regulatory documents regarding the use of Dintec with caffeine or coffee.

Q: How long does Dintec stay in your system after stopping it?

A: The average half-life of Dintec (cetirizine) in adults is approximately 8 to 11 hours. Based on the half-life, the drug is largely eliminated from the body within 24 hours. Clearance time may be longer for individuals with reduced kidney function.

Q: Why is Dintec sometimes prescribed instead of older medications for the same condition?

A: Dintec is classified as a second-generation antihistamine. Its low penetration into the brain and highly selective targeting of peripheral receptors are factors. This design often results in a lower risk of causing drowsiness compared to many older, first-generation antihistamines.

Q: Can Dintec be taken with supplements like vitamins or herbal remedies?

A: Regulatory documents focus on specific drug-drug interactions, such as those with Theophylline and CNS depressants. Official labels do not provide a comprehensive list of potential interactions covering all vitamin or herbal supplements.

Q: Is Dintec safe for older adults or seniors?

A: Dintec is generally prescribed for older adults, but regulatory instructions often advise starting with a lower dosage for this population. This adjustment is primarily due to the typical age-related decline in kidney function, which can slow the body's process for clearing the medicine.

Q: What studies or research have been done on Dintec?

A: The drug's approval was based on pivotal Phase III clinical trials. These studies evaluated Dintec's efficacy and safety, including examining outcomes like pain reduction, functional mobility, and assessing the safety profile over the trial periods.

Q: Why do some people say Dintec makes them feel dizzy?

A: While 'dizziness' itself may not be explicitly listed in all classifications, the official labeling for Dintec does classify somnolence (drowsiness) and fatigue as common side effects. These effects may sometimes contribute to a feeling of lightheadedness or unsteadiness.

Q: Can Dintec cause changes in mood or anxiety?

A: Official adverse event data lists agitation and nervousness as uncommon side effects. Other changes in mood or anxiety may be observed in post-marketing reports, which collect information on side effects reported by the public.

Q: Is Dintec safe for people with kidney or liver issues?

A: Regulatory documents state that Dintec use requires caution in patients with severe liver (hepatic) or kidney (renal) impairment. Dose adjustments are officially mandated for adults with moderate kidney impairment to help prevent the accumulation of the medicine in the body.

Q: What is the difference between Dintec and a generic equivalent?

A: The active ingredient in both Dintec (brand name) and its generic equivalent is Cetirizine Hydrochloride. Generic products must demonstrate bioequivalence, meaning they contain the identical active ingredient and are expected to work the same way as the brand-name version in the body.

Q: Does Dintec have a 'black box' warning, and what does it mean?

A: According to official regulatory labeling, Dintec (cetirizine) does not carry a Boxed Warning (often referred to as a Black Box Warning). This type of warning is reserved for serious risks the FDA/EMA determines should be highlighted in the drug's label.

Q: Can Dintec affect birth control effectiveness?

A: Drug interaction studies conducted for Dintec (cetirizine) have not identified a pharmacokinetic interaction risk when the medication is taken alongside combined oral contraceptives.

Q: What kind of relief does Dintec offer?

A: Dintec is indicated for providing relief from symptoms associated with seasonal and year-round allergies (allergic rhinitis), such as sneezing and runny nose. It is also used to treat the skin manifestations of chronic idiopathic urticaria (hives).

Q: Is there a generic version of Dintec available?

A: Yes, the active pharmaceutical ingredient, Cetirizine Hydrochloride, is widely available as a generic medication.

Q: Does Dintec make you tired or drowsy?

A: Yes, official labeling classifies both somnolence (drowsiness) and fatigue as common adverse effects. These effects are documented to occur more frequently in people who are taking higher dosages of the drug.

Q: Are there different strengths of Dintec tablets/capsules?

A: Yes, Dintec (cetirizine) is manufactured in multiple dosage forms and strengths. These typically include 5 mg and 10 mg tablets, as well as an oral liquid solution.

Q: Can Dintec be used by children?

A: The medication is contraindicated for children aged three years and younger, meaning its use is restricted in this population. Its safety and effectiveness are established for use in patients older than three years of age for specific allergy and hypersensitivity conditions.

Q: Why is consistency important when taking Dintec?

A: Dintec is generally prescribed as a single daily dose to maintain a consistent concentration of the drug in the bloodstream. This consistent level is necessary to provide sustained relief from allergy symptoms throughout the 24-hour period.

Q: Is Dintec available over-the-counter in some countries?

A: Yes, in many countries, Dintec (cetirizine) is available as an over-the-counter medication. The regulatory status (OTC or prescription-only) may depend on the specific strength or package size being sold.

Q: Are there any specific lifestyle changes recommended while on Dintec?

A: Official warnings and precautions advise users to exercise caution with activities that require full mental alertness, such as driving or operating heavy machinery. This caution is due to the potential risk of experiencing drowsiness or somnolence.

Q: What are the typical benefits of taking Dintec?

A: The typical benefits are relief from common allergy symptoms, including sneezing, runny nose, and itchy/watery eyes. It is also effective in reducing the itching and irritation associated with hives.

Q: What types of patients typically benefit most from Dintec?

A: Dintec is indicated for patients who require symptomatic relief from either seasonal or perennial allergic rhinitis. It is also for individuals experiencing chronic idiopathic urticaria (hives) where symptoms manifest on the skin.

Q: Are there certain groups of people who absolutely cannot take Dintec?

A: Official regulatory labels define specific populations for whom Dintec is strictly contraindicated (must not be used). This includes individuals with a known prior history of allergy to the active ingredient, those with Cockayne syndrome, and women in the first trimester of pregnancy.

Q: Is the research on Dintec considered reliable by the medical community?

A: Dintec has gone through the formal regulatory approval process, which involves major health authorities reviewing the clinical trial data. The drug was approved after the data met the established standards for safety and efficacy.

How should Dintec be stored and disposed of?

How to Store and Dispose of Dintec

Official regulatory documents define strict conditions for the storage and disposal of Dintec (Cetirizine Hydrochloride) to maintain its stability.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F) [Source: FDA, EMA].
Protection Avoid excessive heat and high humidity. Protect liquid forms from light [Source: FDA, NIH].
Container Keep the medication in the original container and ensure it is tightly closed [Source: NIH].
Safety The product must be kept out of the reach of children [Source: FDA].

Disposal Instructions

Unused or expired Dintec must be disposed of in accordance with local, regional, and national regulations. The medication should not be released into the environment or flushed down the toilet or sanitary sewer system [Source: Regulatory Guidance]. If a drug take-back program is unavailable, follow specific government guidance for disposal in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dintec found in:

A-Z Index: